|
|
 |
|
Viewing report
|
|
|
|
Bellco Health Corp. (Inactive): SWOT Analysis & Company Profile
Business Review, Jan 2011, Pages: 30
Synopsis
Business Review’s Bellco Health Corp. (Inactive) contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company.
Summary
This SWOT Analysis company profile is a crucial resource for industry executives and anyone looking to quickly understand the key information concerning Bellco Health Corp. (Inactive)’s business.
Business Review’s “Bellco Health Corp. (Inactive) SWOT Analysis & Company Profile” reports utilize a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
Business Review strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about (Bellco Health Corp. (Inactive)) for business intelligence requirements
- Studies and presents Bellco Health Corp. (Inactive)’s strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- The profile contains business operations, the company history, major products and services, prospects, key competitors, structure and key employees, locations and subsidiaries.
Reasons To Buy
- Quickly enhance your understanding of the company.
- Obtain details and analysis of the market and competitors as well as internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors’ businesses better.
- Recognize potential partnerships and suppliers.
- Obtain yearly profitability figures
Key Highlights
Bellco Health Corp.(Bellco) engages in the distribution of pharmaceutical and health care products throughout the US. Operating through four subsidiaries: Bellco Drug Corp, American Medical Distributors, Dialysis Purchasing Alliance, and Clinical Outcomes Resource Application; the company is recognized as one of the leading distributors of generic drugs to pharmacies nationally. In October 2007, AmerisourceBergen Corporation acquired Bellco for a cash consideration of $190 million. Also, in September 2008, AmerisourceBergen integrated Bellco into its two divisions namely AmerisourceBergen Drug Corporation and the AmerisourceBergen Specialty Group. Bellco is headquartered in Florida, the US.
|
|
|
|
